Karl Elderkin

Mr. Elderkin founded Athenian Venture Partners in 1997 and serves as its Managing Partner. Active in both the IT and the Healthcare investment practices, Mr. Elderkin has 24 years of venture capital experience in both sectors. Mr. Elderkin currently serves on the boards of several of Athenian’s portfolio companies, including: Manta Media (director), Prioria Robotics (director) and Sendio (observer). He previously served on the boards of Phobos Corporation, StorageApps, Chaparral Network Storage, Alloptic, Pain Therapeutics and CancerVax, among others. With expertise in strategy, manufacturing, capital planning and financial structuring, Mr. Elderkin has led, co-led, and participated in numerous IPOs and strategic acquisitions as well as over 100 financing transactions. Prior to Athenian, Mr. Elderkin was co-head of Generics Asset Management (“GAM”), the London-based venture capital arm of Generics Group, PLC, a technology consultancy in Cambridge, England. At GAM, he shared responsibility for the Fund’s management and its investment activities, covering a range of technologies and industries including communications and medical devices. Earlier with Generics, he was a management consultant. Prior to his management consulting and venture capital career, Mr. Elderkin spent seven years in engineering, manufacturing and capital investment management with Texas Instruments in Attleboro, Massachusetts. Mr. Elderkin earned a BS in Mechanical Engineering from Cornell University and an MBA from the Wharton School at the University of Pennsylvania, with international graduate studies at London Business School.